Source: Monsanto Company

Monsanto Company has acquired Divergence, Inc., a privately-held St. Louis-based biotechnology research and development company. Divergence's current focus is its work with parasitic nematodes, including developing biotechnology traits for nematode control and nematicides with novel modes of action and superior safety profiles.

"Nematodes are one of the most challenging agricultural pests farmers face each year, and we've seen them become more pervasive," said Robb Fraley, Ph.D., Monsanto's chief technology officer. "These pests cost farmers millions in damages annually to crops like corn, soy, cotton and vegetables. Divergence has promising tools in its pipeline, including a nematicide which we believe could be used as a valuable seed treatment formulation to maximize the performance potential of the seeds and traits farmers plant." 

Original news release